Bazsites.com Renal Pelvis And Ureter Cancer, Transitional Cell
Directory Topics
On the Web
- NCI: Transitional Cell Cancer - Information about transitional cell cancer of the renal pelvis and ureter. Includes prevention, genetics, causes, clinical trials, research, statistics, and treatment options.
- Learn About Renal Pelvis and Ureter Cancer - Description of the disease, medical tests, treatments, and other topics surrounding genitourinary cancer.
Wikipedia Articles
- Epoetin alfa - Epoetin alfa (rINN) (IPA: ) is a synthetic form of erythropoietin. It stimulates erythropoiesis (increases red blood cell levels) and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy.
- Sorafenib - Sorafenib (rINN), marketed as Nexavar by Bayer, is a drug approved for the treatment of advanced renal cell carcinoma (primary kidney cancer). It has also received "Fast Track" designation by the FDAhttps://lnn605.
- Sunitinib - Sunitinib (marketed as Sutent, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on January 26, 2006. Sunitinib was the first cancer drug simultaneously approved for two different indications.
- Darbepoetin alfa - Darbepoetin alfa (rINN) (IPA: ) is a synthetic form of erythropoietin. It stimulates erythropoiesis (increases red blood cell levels) and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy.
- Cancer stem cell - Cancer stem cell hypothesis states that tumors arise from cells termed cancer stem cells that have properties of adult stem cells, particularly the abilities to self-renew and differentiate into multiple cell types, and that these cells persist in tumors as a distinct population that likely causes disease relapse and ...